NeuroFlow and ChristianaCare Partner to Enhance Maternal Mental Health Screening

NoahAI News ·
NeuroFlow and ChristianaCare Partner to Enhance Maternal Mental Health Screening

In a significant move to address the critical issue of maternal mental health, behavioral health technology company NeuroFlow has joined forces with ChristianaCare, a Delaware-based health system. This collaboration aims to provide comprehensive mental health screening and support for pregnant and postpartum patients across ChristianaCare's network.

Expanding Access to Mental Health Resources

The partnership will leverage NeuroFlow's advanced platform to offer standardized mental health screenings to patients at ChristianaCare's obstetrics and gynecology clinics. Patients will have free access to personalized educational content covering a wide range of topics related to maternal mental health. This initiative is designed to help ChristianaCare better identify and address mental health risks among its patient population.

Dr. Tom Zaubler, Chief Behavioral Health Officer at NeuroFlow, emphasized the importance of this approach, stating, "No matter how well staffed they are, no one has the resources to take care of everyone endorsing a mental health problem." The program aims to fill this gap by providing continuous support between appointments and proactively identifying patients who may need additional assistance.

Addressing a Critical Healthcare Gap

The collaboration comes at a crucial time, as recent statistics highlight the pressing need for improved maternal mental health care:

  • The American College of Obstetricians and Gynecologists recommends screening for depression and anxiety across prenatal, pregnancy, and postpartum visits.
  • Despite this recommendation, 75% of pregnant individuals affected by mental health symptoms do not receive care.
  • Only three states—California, West Virginia, and Florida—currently mandate that OB providers conduct screenings during pregnancy and link these screenings with state support services.

ChristianaCare, which delivers more than 6,000 babies annually, will initially implement NeuroFlow's platform across 15 OB-GYN clinics. There are plans to expand the program to hospitals and the health system's multidisciplinary Center for Women's Emotional Wellness in the future.

Advanced Features and Safety Protocols

NeuroFlow's platform offers a range of tools to support maternal mental health:

  • Standardized screening tools for various mental health conditions
  • Stress, sleep, and mood trackers providing real-time assessments of patient well-being
  • Safety protocols for high-acuity needs, including immediate clinical team notifications and emergency resource recommendations
  • Follow-up calls for suicide safety assessments when necessary

The collaboration also includes NeuroFlow's suite of analytics products, which will help ChristianaCare understand population risk and tailor interventions accordingly.

As this partnership unfolds, it represents a significant step forward in addressing the often-overlooked issue of maternal mental health, potentially setting a new standard for care in obstetrics and gynecology practices nationwide.

References